statistiche ricercatore

Continente	#
EU - Europa	1.108
NA - Nord America	755
AS - Asia	443
SA - Sud America	77
AF - Africa	25
OC - Oceania	2
Continente sconosciuto - Info sul continente non disponibili	1
Totale	2.411

Nazione	#
US - Stati Uniti d'America	724
IT - Italia	337
GB - Regno Unito	207
RU - Federazione Russa	205
CN - Cina	133
SG - Singapore	127
IE - Irlanda	101
BR - Brasile	65
FR - Francia	45
SE - Svezia	41
VN - Vietnam	41
KR - Corea	31
DE - Germania	29
FI - Finlandia	27
HK - Hong Kong	26
AT - Austria	25
UA - Ucraina	25
IN - India	23
CA - Canada	19
NL - Olanda	18
BD - Bangladesh	15
ES - Italia	15
BE - Belgio	12
ZA - Sudafrica	11
IQ - Iraq	8
JP - Giappone	8
PK - Pakistan	7
PL - Polonia	7
TR - Turchia	7
EC - Ecuador	6
KE - Kenya	5
MX - Messico	5
RO - Romania	5
AR - Argentina	4
JM - Giamaica	4
CZ - Repubblica Ceca	3
ID - Indonesia	3
AU - Australia	2
CI - Costa d'Avorio	2
NG - Nigeria	2
UZ - Uzbekistan	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
AO - Angola	1
AZ - Azerbaigian	1
BG - Bulgaria	1
BH - Bahrain	1
CG - Congo	1
CH - Svizzera	1
CL - Cile	1
CR - Costa Rica	1
DZ - Algeria	1
EG - Egitto	1
EU - Europa	1
GD - Grenada	1
IR - Iran	1
KH - Cambogia	1
LA - Repubblica Popolare Democratica del Laos	1
LT - Lituania	1
MA - Marocco	1
MD - Moldavia	1
MK - Macedonia	1
NP - Nepal	1
OM - Oman	1
PE - Perù	1
PH - Filippine	1
PR - Porto Rico	1
PS - Palestinian Territory	1
SA - Arabia Saudita	1
TW - Taiwan	1
Totale	2.411

Nome	#
Ruthenium-catalyzed synthesis of 5-amino-1,2,3-triazole-4-carboxylates for triazole-based scaffolds: Beyond the Dimroth rearrangement	366
A novel bioresponsive self-immolative spacer based on aza-quinone methide reactivity for the controlled release of thiols, phenols, amines, sulfonamides or amides	323
Antibody drug conjugates (ADCs) charged with HDAC inhibitor for targeted epigenetic modulation	323
Hedgehog pathway inhibitors of the acylthiourea and acylguanidine class show antitumor activity on colon cancer in vitro and in vivo	314
ErbB2 targeted epigenetic modulation: anti-tumor efficacy of the ADC Trastuzumab-HDACi ST8176AA1	275
Targeting GLI1 and GLI2 with small molecule inhibitors to suppress GLI-dependent transcription and tumor growth	262
Histone Deacetylase Inhibitors-based antibody drug conjugates (ADCs) and use in therapy	262
Quinolines and Oxazino-quinoline derivatives as small molecule GLI1 inhibitors identified by virtual screening	176
Fluoromethylcarnitine, a novel inhibitor of trimethylamine levels in trimethylaminuria and trimethylamine N-oxide related disorders	148
Totale	2.449

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	126	14	10	11	5	13	6	4	3	3	12	20	25
2022/2023	191	5	19	23	17	20	35	15	15	23	7	6	6
2023/2024	217	8	11	17	16	6	31	62	11	0	8	17	30
2024/2025	365	28	13	40	26	32	16	29	33	40	16	26	66
2025/2026	993	61	96	92	172	205	34	84	30	58	69	36	56
2026/2027	1	1	0	0	0	0	0	0	0	0	0	0	0
Totale													2.449